Established in 2013, Gemstone Biotherapeutics LLC is a pre-clinical research and development initiative based in Baltimore, Maryland. Gemstone is dedicated to the field of regenerative medicine and specializes in developing improved methods for advanced wound healing and tissue vascularization using licensed technology from Johns Hopkins University. Our core technologies include innovative polymeric hydrogels and stem cell engineering methodologies.